Metabolic Response to Variations in Dietary Glycemic Index

The goal of this study is to compare metabolic response to variations in dietary glycemic index in healthy participants. The main questions it aims to answer are:

• What are the metabolic hunger and food intake responses to different levels of glycemic index on the background of otherwise constant macronutrient composition? Participants will come to the lab after an overnight fast and body composition will be tested by bio-impedance analysis and magnetic resonance imaging. They will then be randomized to eat one of three standardized breakfasts varying in the glycemic index. Circulating glucose levels will be monitored using a continuous glucose monitor and blood samples will be collected to measure metabolic and hormone factors in the serum. Participants will also rate their hunger at 0, 30, 60, 120, 180, 240 and 300 minutes. After 5 hours they will eat a free choice meal from a standardized selection buffet (test meal).

Study Overview

Detailed Description

The primary variable in this study is the food energy intake at the test meal consumed 5 hours after the dietary intervention meal on day1 of the experiment, compared to the intake of the same test meal consumed on day 0. The investigators performed a power analysis using this outcome measure to inform the sample size if the data were analysed using one-way ANOVA. The number of levels in the study is 3, the investigators set the effect size as a difference between means of the groups of 200 kJ. From a pilot study of repeated measurements across individuals the investigators observed the standard deviation of the difference between repeated intakes was 372 kJ. The investigators set the power value of the study at 80 %. This analysis suggested a sample of 39 individuals per group. To account for individuals potentially not completing the study, the investigators aimed to recruit 40 participants each group and 120 participants will be recruited in total.

The experiment includes the pre-test, the dietary intervention and postprandial monitoring.

Pre-test. The participants will be fed a test meal (free choice from buffet) at noon the day before the experiment (day 0). The food preference and total energy intake will be assessed. On the experimental day (day 1), the participants will be asked to attend the laboratory in the morning after an overnight fast (10 hours fasting). The body composition will be measured using a bio-impedance and magnetic resonance imaging, Then the participants will be guided to wear a continuous glucose monitoring system (CGMS) and the CGMS is under initialization for 2 hours. Also, a peripheral venous catheter (PVC) will be placed in the back of the hand, upper arm or elbow socket and 6 ml of fasting peripheral blood will be drawn (0 min).

Dietary intervention. 60 male and 60 female participants will be randomly divided into three groups: low, moderate and high glycemic index groups. Each group consists of 20 males and females. They will be feed by standardized meal with constant fat, protein and carbohydrate % but differing in the source of the carbohydrates.

Postprandial test. The test includes the testing of physiological indices during and after the intervention meal. In addition to continuously recording the changes in blood glucose by CGMS, the hunger rate will be accessed at 30 minutes intervals and peripheral blood will be collected by PVC (6 ml each time) at 30, 60, 120, 180, 240 and 300 min after the meal. When the participants have finished the tests during 300 min, a test meal will be provided identical to that provided on day 0. The effect of the standard meal on the total energy intake and macronutrient (carbohydrate, protein, fat) supply will be accessed in absolute amounts and the change between day 0 and day 1.

Study Type

Interventional

Enrollment (Estimated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Guangdong
      • Shenzhen, Guangdong, China
        • Recruiting
        • Shenzhen Institute of Advanced Technology
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Healthy adults (both men and women)
  • 18-40 years old
  • 18.5 ≤ BMI (body mass index)<24 kg/m2

Exclusion Criteria:

  • Those who have undergone surgery in the past 6 months.
  • People are requiring long-term medication.
  • People have metabolic diseases, like diabetes, hypoglycemia, gout, osteoporosis, et al.
  • Those who have recently lost weight for various medical reasons (e.g. cancer, etc.).
  • People are losing weight by tablets.
  • People are suffering from infectious diseases (e.g. HIV, etc.)
  • People have blood phobia, pathological hypo or hyper tension.
  • People with impaired glucose tolerance.
  • Pregnant and lactation women.
  • Those who are afflicted with claustrophobia.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: High glycemic index
The participants will be fed a fixed calorie meal, which is high glycemic index with constant fat and protein.
Composition (by proportion of calories) of meal: 60% carbohydrate (glycemic index:>70), 20% fat and 20% protein.
Experimental: Medium glycemic index
The participants will be fed a fixed calorie meal, which is medium glycemic index with constant fat and protein.
Composition (by proportion of calories) of meal: 60% carbohydrate (glycemic index:55-70), 20% fat and 20% protein.
Experimental: Low glycemic index
The participants will be fed a fixed calorie meal, which is low glycemic index with constant fat and protein.
Composition (by proportion of calories) of meal: 60% carbohydrate (glycemic index:<55), 20% fat and 20% protein.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in energy intake of test meal between day 0 and day 1
Time Frame: Change in intake between day 0 and day 1

The food intake will be assessed objectively by use of a feeding table. The test meal will be provided as lunch, and food types available on the table include staples, vegetables, mushrooms, meat, soy products, desserts, beverages and water. All types of food are unlimited. Food consumption will be recorded continuously by balances concealed under each food dish. The food energy density for each food will be measured by bomb calorimetry in kJ/g, and energy intake will be calculated as the product of the grams of each food eaten multiplied by the respective energy density and then summed, as kJ.

This test meal intake is measured on day 0 and then a repeat test meal measure is made under identical conditions on day 1. On day 1 an intervention meal is also consumed five hours before the test meal is consumed. On day 0 no such meal is consumed. The outcome measure is the change in food intake (kJ) between day 0 and day 1 reflecting the impact of the intervention meal.

Change in intake between day 0 and day 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
circulating hormones
Time Frame: fasting, postprandial 30, 60, 120, 180, 240 and 300 minutes.
Nurses will collect the blood samples on day 1. Levels of circulating hormones (insulin, leptin, glycogen,etc) in the serum will be measured by ELISA(Bio Tek, Synergy4) in mmol/L.
fasting, postprandial 30, 60, 120, 180, 240 and 300 minutes.
self reported hunger
Time Frame: fasting, postprandial 30, 60, 120, 180, 240 and 300 minutes.
Self reported hunger will be tested by rating scale question.
fasting, postprandial 30, 60, 120, 180, 240 and 300 minutes.
levels of circulating metabolic fuels
Time Frame: fasting, postprandial 30, 60, 120, 180, 240 and 300 minutes.
Nurses will collect the blood samples on day 1. Circulating lactate, free-fatty acids, triglycerides etc in mmol/L will be measured by ELISA(Bio Tek, Synergy4).
fasting, postprandial 30, 60, 120, 180, 240 and 300 minutes.
postprandial glucose
Time Frame: fasting glucose and postprandial glucose for 5 hours
Standardized meal with different levels of glycemic index( low level: ≤ 55, moderate level: 55 < GI ≤ 70, high level: > 70) will be provided as breakfast on day 1. Independent of the GI, the energy supply ratio of macronutrients carbohydrate, protein and fat will be fixed at 60 %, 20 % and 20 % respectively. Glucose concentration after the standardized meal will be recorded by the continuous glucose monitoring system(Medtronic) in mmol/L during 5 hours.
fasting glucose and postprandial glucose for 5 hours

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
fat mass tested by bioelectrical impedance analysis
Time Frame: pre measurement
Fat mass will be tested by bioelectrical impedance analysis(Tanita, MC-980) in kg.
pre measurement
fat mass tested by magnetic resonance imaging
Time Frame: pre measurement
Fat mass will be tested by magnetic resonance imaging(Shanghai united imaging, uMR790) in %.
pre measurement
fat free mass tested by bioelectrical impedance analysis
Time Frame: pre measurement
Fat free mass will be tested by bioelectrical impedance analysis(Tanita, MC-980) in kg.
pre measurement
fat free mass tested by magnetic resonance imaging
Time Frame: pre measurement
Fat free mass will be tested by magnetic resonance imaging(Shanghai united imaging, uMR790) in %.
pre measurement
sex difference in energy intake
Time Frame: pre measurement
The impact of sex on energy intake will be explored by correlation analysis.
pre measurement
sex difference in circulating hormones
Time Frame: pre measurement
The impact of sex on circulating hormones will be explored by correlation analysis.
pre measurement
sex difference in postprandial glucose
Time Frame: pre measurement
The impact of sex on postprandial glucose will be explored by correlation analysis.
pre measurement
sex difference in self reported hunger
Time Frame: pre measurement
The impact of sex on self reported hunger will be explored by correlation analysis.
pre measurement
sex difference in circulating metabolic fuels
Time Frame: pre measurement
The impact of sex on circulating metabolic fuels will be explored by correlation analysis.
pre measurement
sex difference in fat mass
Time Frame: pre measurement
The impact of sex on fat mass will be explored by correlation analysis.
pre measurement
sex difference in fat free mass
Time Frame: pre measurement
The impact of sex on fat free mass will be explored by correlation analysis.
pre measurement

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 13, 2023

Primary Completion (Estimated)

December 1, 2024

Study Completion (Estimated)

December 1, 2024

Study Registration Dates

First Submitted

February 17, 2023

First Submitted That Met QC Criteria

March 27, 2023

First Posted (Actual)

April 7, 2023

Study Record Updates

Last Update Posted (Actual)

April 3, 2024

Last Update Submitted That Met QC Criteria

April 2, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • SIAT-IRB-221115-H0618

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on High glycemic index

3
Subscribe